Company Data
Kazia Therapeutics Limited
Ticker
KZIA
Current Price
$12.63 -8.28%
Market Cap
$144.3M
Price Target
Refer to Report
Volume
612.1K
52wk Range
$4.86 - $17.4
Overview
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing GDC-0084, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others.